Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binbin Yue

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Human Pathology|July 19, 2014
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinomaMartin J Edelman, Josephine Feliciano, Binbin Yue, et al.
Journal of the American Chemical Society|December 29, 2022
Insulator-to-Superconductor Transition in Quasi-One-Dimensional HfS<sub>3</sub> under PressureBinbin Yue, Wei Zhong, Wen Deng, et al.
Annals of Clinical and Translational Neurology|May 16, 2018
Progranulin levels in blood in Alzheimer's disease and mild cognitive impairmentYonatan A Cooper, Daniel Nachun, Deepika Dokuru, et al.
Inflammation|May 8, 2014
Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritisYasuko Yamamoto, Masao Takemura, Ginette Serrero, et al.
Cancers|January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
Cancer Management and Research|October 17, 2018
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survivalThomas Greither, Kersten Fischer, Gerit Theil, et al.
Life (Basel, Switzerland)|May 28, 2022
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer PatientsAlexander Fichte, Angela Neumann, Katrin Weigelt, et al.
Cells|August 7, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer PatientsMarkus Eckstein, Verena Lieb, Rudolf Jung, et al.
Diagnostic Pathology|August 10, 2016
Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic IndexGinette Serrero, Douglas M Hawkins, Pablo A Bejarano, et al.
Breast Cancer Research : BCR|February 10, 2012
Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinomaGinette Serrero, Douglas M Hawkins, Binbin Yue, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Human Pathology|July 19, 2014
GP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinomaMartin J Edelman, Josephine Feliciano, Binbin Yue, et al.
Journal of the American Chemical Society|December 29, 2022
Insulator-to-Superconductor Transition in Quasi-One-Dimensional HfS<sub>3</sub> under PressureBinbin Yue, Wei Zhong, Wen Deng, et al.
Annals of Clinical and Translational Neurology|May 16, 2018
Progranulin levels in blood in Alzheimer's disease and mild cognitive impairmentYonatan A Cooper, Daniel Nachun, Deepika Dokuru, et al.
Inflammation|May 8, 2014
Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritisYasuko Yamamoto, Masao Takemura, Ginette Serrero, et al.
Cancers|January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
Cancer Management and Research|October 17, 2018
Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survivalThomas Greither, Kersten Fischer, Gerit Theil, et al.
Life (Basel, Switzerland)|May 28, 2022
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer PatientsAlexander Fichte, Angela Neumann, Katrin Weigelt, et al.
Cells|August 7, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer PatientsMarkus Eckstein, Verena Lieb, Rudolf Jung, et al.
Diagnostic Pathology|August 10, 2016
Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic IndexGinette Serrero, Douglas M Hawkins, Pablo A Bejarano, et al.
Breast Cancer Research : BCR|February 10, 2012
Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinomaGinette Serrero, Douglas M Hawkins, Binbin Yue, et al.
Pageof 4